BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32274573)

  • 1. Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function.
    Hillebrand P; Hoppe B
    Pediatr Nephrol; 2020 Jul; 35(7):1227-1233. PubMed ID: 32274573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
    Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
    Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.
    Milliner DS; Cochat P; Hulton SA; Harambat J; Banos A; Dehmel B; Lindner E
    Pediatr Nephrol; 2021 Jul; 36(7):1785-1793. PubMed ID: 33515281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort.
    Shah RJ; Vaughan LE; Enders FT; Milliner DS; Lieske JC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
    Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U
    Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Milliner D; Hoppe B; Groothoff J
    Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
    Sas DJ; Mara K; Mehta RA; Seide BM; Banks CJ; Danese DS; McGregor TL; Lieske JC; Milliner DS
    Pediatr Nephrol; 2024 Jan; 39(1):141-148. PubMed ID: 37458799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
    Garrelfs SF; Frishberg Y; Hulton SA; Koren MJ; O'Riordan WD; Cochat P; Deschênes G; Shasha-Lavsky H; Saland JM; Van't Hoff WG; Fuster DG; Magen D; Moochhala SH; Schalk G; Simkova E; Groothoff JW; Sas DJ; Meliambro KA; Lu J; Sweetser MT; Garg PP; Vaishnaw AK; Gansner JM; McGregor TL; Lieske JC;
    N Engl J Med; 2021 Apr; 384(13):1216-1226. PubMed ID: 33789010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B; Beck B; Gatter N; von Unruh G; Tischer A; Hesse A; Laube N; Kaul P; Sidhu H
    Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End Points for Clinical Trials in Primary Hyperoxaluria.
    Milliner DS; McGregor TL; Thompson A; Dehmel B; Knight J; Rosskamp R; Blank M; Yang S; Fargue S; Rumsby G; Groothoff J; Allain M; West M; Hollander K; Lowther WT; Lieske JC
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):1056-1065. PubMed ID: 32165440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxalate level in pediatric calcium stone formers with or without secondary hyperoxaluria.
    Sikora P; Beck B; Zajaczkowska M; Hoppe B
    Urol Res; 2009 Apr; 37(2):101-5. PubMed ID: 19183975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3.
    Martin-Higueras C; Garrelfs SF; Groothoff JW; Jacob DE; Moochhala SH; Bacchetta J; Acquaviva C; Zaniew M; Sikora P; Beck BB; Hoppe B
    Kidney Int; 2021 Sep; 100(3):621-635. PubMed ID: 33865885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.
    Zhao F; Bergstralh EJ; Mehta RA; Vaughan LE; Olson JB; Seide BM; Meek AM; Cogal AG; Lieske JC; Milliner DS;
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):119-26. PubMed ID: 26656319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.
    Wannous H
    Pediatr Nephrol; 2023 Aug; 38(8):2643-2648. PubMed ID: 36917293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
    Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.